Furthermore, self-sufficient production of IL-15 by the NK:BOB1-TCR product showed a clear beneficial TCR-mediated effect in vivo, whereby NK:BOB1-TCR/IL-15 cells were able to clear the tumor and persevere this effect for a longer time compared to NK:BOB1-TCR cells. The gene discussed is IL15; the disease is neoplasm.